Related Experiment Video
Updated: Feb 5, 2026

Determination of Chemical Inhibitor Efficiency against Intracellular Toxoplasma Gondii Growth Using a Luciferase-Based Growth Assay
Published on: April 29, 2020
Chemical Instability and Promiscuity of Arylmethylidenepyrazolinone-Based MDMX Inhibitors
Jakub Stefaniak1,2,3, Andrew M Lewis1,2, Daniel Conole3
1Structural Genomics Consortium, Nuffield Department of Medicine , University of Oxford , Oxford , United Kingdom.
Abstract:
Targeting the protein-protein interaction between p53 and MDM2/MDMX (MDM4) represents an attractive anticancer strategy for the treatment of p53-competent tumors. Several selective and potent MDM2 inhibitors have been developed and entered the clinic; however, the repertoire of MDMX antagonists is still limited. The arylmethylidenepyrazolinone SJ-172550 has been reported as a selective MDMX antagonist; yet, uncertainties about its mechanism of action have raised doubts about its use as a chemical probe. Here, we show that, in addition to its unclear mode of action, SJ-172550 is unstable in aqueous buffers, giving rise to side products of unknown biological activity. Using an SJ-172550-derived affinity probe, we observed promiscuous binding to cellular proteins whereas cellular thermal shift assays did not reveal a stabilizing effect on MDMX. Overall, our results raise further questions about the interpretation of data using SJ-172550 and related compounds to investigate cellular phenotypes.
Insights
The arylmethylidenepyrazolinone SJ-172550 is an unstable MDMX antagonist with an unclear mechanism of action. This compound exhibits promiscuous binding, questioning its utility as a chemical probe in cancer research.
Area of Science:
- Oncology
- Molecular Biology
- Drug Discovery
Background:
- Targeting p53-MDM2/MDMX protein-protein interactions is a key anticancer strategy.
- MDM2 inhibitors are clinically available, but MDMX antagonists are limited.
- SJ-172550 was proposed as a selective MDMX antagonist but its mechanism is uncertain.
Purpose of the Study:
- To investigate the mechanism of action and utility of SJ-172550 as an MDMX antagonist.
- To assess the stability and specificity of SJ-172550 in biological systems.
Main Methods:
- Chemical stability assays in aqueous buffers.
- Affinity probe pull-down assays.
- Cellular thermal shift assays (CETSA).
Main Results:
- SJ-172550 is unstable in aqueous buffers, forming unknown side products.
- An SJ-172550-derived affinity probe showed promiscuous binding to cellular proteins.
- CETSA did not confirm SJ-172550 binding or stabilization of MDMX.
Conclusions:
- SJ-172550's instability and promiscuous binding raise concerns about its use as a selective MDMX chemical probe.
- Further investigation is needed to validate SJ-172550 and related compounds for studying cellular phenotypes.
- The development of reliable MDMX antagonists remains a critical challenge in cancer therapy.
Related Concept Videos
Microtubule Instability
Eukaryotic Transcription Inhibitors
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
Chemical Formulas
Chemical Equations
Chemical Reactions
Chemical Reactions Rearrange Atoms into New Substances
A chemical reaction takes starting materials—the reactants—and changes them...
Types of Chemical Bonds

